The peptide GHK-Cu is known for its incredible skin benefitsit helps make skin firmer, improves elasticity, and can reduce the appearance of fine lines and wrinkles by stimulating collagen production
The FDA's Category 2 classification makes clinical development in the United States more difficult, not less

its relevance to retatrutide specifically is not yet established A history of pancreatitis or significant gastrointestinal disease Gallbladder disease , including a history of gallstones or cholecystitis Diabetes mellitus , particularly if managed with insulin or sulphonylureas, due to hypoglycaemia risk Cardiovascular disease , including arrhythmias or recent cardiac events Renal or hepatic impairment , which may affect tolerability and increase the risk of dehydration-related complications Pregnancy or breastfeeding no safety data exist for retatrutide in these groups Use of oral medicines where absorption may be affected by delayed gastric emptying , such as levothyroxine or combined oral contraceptives Seek urgent medical attention if you experience severe or persistent nausea or vomiting, persistent abdominal pain (which may indicate pancreatitis or gallbladder disease), signs of an allergic reaction (rash, swelling, difficulty breathing), chest pain, palpitations, or signs of dehydration

Its a real disruption for a real group of people who were using this thing carefully and feeling results and its a non-event for people who were treating it like a supplement you throw in a smoothie
The margin between proper storage and complete product failure is narrower than most protocols acknowledge
After treatment You may notice: Mild muscle soreness Slight tenderness Small redness around the injection site These symptoms normally disappear quickly